SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $241,203 | -98.3% | 1,750 | -98.4% | 0.00% | -97.4% |
| Q4 2022 | $13,903,934 | -8.6% | 107,300 | -22.0% | 0.08% | +9.9% |
| Q3 2022 | $15,205,000 | +13.5% | 137,550 | -23.0% | 0.07% | +44.9% |
| Q2 2022 | $13,392,000 | +27.1% | 178,650 | +32.4% | 0.05% | +32.4% |
| Q1 2022 | $10,538,000 | -50.7% | 134,900 | -43.2% | 0.04% | -49.3% |
| Q4 2021 | $21,378,000 | +5126.9% | 237,400 | +4229.0% | 0.07% | +7200.0% |
| Q1 2021 | $409,000 | -98.6% | 5,484 | -96.7% | 0.00% | -99.0% |
| Q4 2020 | $28,372,000 | +226.6% | 166,415 | +109.0% | 0.10% | +186.1% |
| Q4 2018 | $8,688,000 | +296.9% | 79,610 | +487.5% | 0.04% | +176.9% |
| Q3 2018 | $2,189,000 | +280.0% | 13,551 | +211.2% | 0.01% | +333.3% |
| Q2 2018 | $576,000 | +2.1% | 4,354 | -42.8% | 0.00% | 0.0% |
| Q1 2018 | $564,000 | -25.2% | 7,612 | -43.9% | 0.00% | -50.0% |
| Q4 2017 | $754,000 | – | 13,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |